Literature DB >> 20838929

Caffeine modulates tau phosphorylation and affects Akt signaling in postmitotic neurons.

Antonio Currais1, Kiyoko Kato, Leonides Canuet, Ryouhei Ishii, Toshihisa Tanaka, Masatoshi Takeda, Salvador Soriano.   

Abstract

Neuronal cell cycle reentry, which is associated with aberrant tau phosphorylation, is thought to be a mechanism of neurodegeneration in AD. Caffeine is a neuroprotective drug known to inhibit the cell cycle, suggesting that its neuroprotective nature may rely, at least in part, on preventing tau abnormalities secondary to its inhibitory effect on neuronal cell cycle-related pathways. Accordingly, we have explored in the present study the impact of caffeine on cell cycle-linked parameters and tau phosphorylation patterns in an attempt to identify molecular clues to its neuroprotective effect. We show that caffeine blocks the cell cycle at G1 phase in neuroblastoma cells and leads to a decrease in tau phosphorylation; similarly, exposure of postmitotic neurons to caffeine led to changes in tau phosphorylation concomitantly with downregulation of Akt signaling. Taken together, our results show a unique impact of caffeine on tau phosphorylation and warrant further investigation to address whether caffeine may help prevent neuronal death by preventing tau abnormalities secondary to aberrant entry into the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20838929     DOI: 10.1007/s12031-010-9444-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

1.  Characterization of nerve growth factor-dependent herpes simplex virus latency in neurons in vitro.

Authors:  C L Wilcox; E M Johnson
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

Review 2.  Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

3.  Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3.

Authors:  M Hong; D C Chen; P S Klein; V M Lee
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

4.  Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells.

Authors:  Stefania Merighi; Prisco Mirandola; Daniela Milani; Katia Varani; Stefania Gessi; Karl-Norbert Klotz; Edward Leung; Pier Giovanni Baraldi; Pier Andrea Borea
Journal:  J Invest Dermatol       Date:  2002-10       Impact factor: 8.551

5.  Neuronal cell cycle re-entry mediates Alzheimer disease-type changes.

Authors:  Andrew McShea; Hyoung-gon Lee; Robert B Petersen; Gemma Casadesus; Inez Vincent; Nancy J Linford; Jens-Oliver Funk; Robert A Shapiro; Mark A Smith
Journal:  Biochim Biophys Acta       Date:  2006-10-03

6.  Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain.

Authors:  Bilal Malik; Antonio Currais; Ana Andres; Christopher Towlson; Didier Pitsi; Ana Nunes; Michael Niblock; Jonathan Cooper; Tibor Hortobágyi; Salvador Soriano
Journal:  Cell Cycle       Date:  2007-12-06       Impact factor: 4.534

7.  Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.

Authors:  Gary W Arendash; Takashi Mori; Chuanhai Cao; Malgorzata Mamcarz; Melissa Runfeldt; Alexander Dickson; Kavon Rezai-Zadeh; Jun Tane; Bruce A Citron; Xiaoyang Lin; Valentina Echeverria; Huntington Potter
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Interactions between glycogen synthase kinase 3beta, protein kinase B, and protein phosphatase 2A in tau phosphorylation in mouse N2a neuroblastoma cells.

Authors:  Xin-Wen Zhou; Bengt Winblad; Zhizhong Guan; Jin-Jing Pei
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

Authors:  Joan Lindsay; Danielle Laurin; René Verreault; Réjean Hébert; Barbara Helliwell; Gerry B Hill; Ian McDowell
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

10.  BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease.

Authors:  Teresa A Evans; Arun K Raina; André Delacourte; Olga Aprelikova; Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Int J Med Sci       Date:  2007-05-12       Impact factor: 3.738

View more
  3 in total

Review 1.  The Neuroprotective Effects of Moderate and Regular Caffeine Consumption in Alzheimer's Disease.

Authors:  Xiangyu Zhou; Lin Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-08-17       Impact factor: 6.543

Review 2.  From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?

Authors:  Vanessa Flaten; Cyril Laurent; Joana E Coelho; Ursula Sandau; Vânia L Batalha; Sylvie Burnouf; Malika Hamdane; Sandrine Humez; Detlev Boison; Luísa V Lopes; Luc Buée; David Blum
Journal:  Biochem Soc Trans       Date:  2014-04       Impact factor: 5.407

Review 3.  Adenosine receptor signalling in Alzheimer's disease.

Authors:  Phuc N H Trinh; Jo-Anne Baltos; Shane D Hellyer; Lauren T May; Karen J Gregory
Journal:  Purinergic Signal       Date:  2022-07-23       Impact factor: 3.950

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.